tiprankstipranks
Trending News
More News >
Nanologica AB (SE:NICA)
:NICA
Sweden Market
Advertisement

Nanologica AB (NICA) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

NICA Financial Forecast

NICA Earnings Forecast

Next quarter’s earnings estimate for NICA is -kr0.10 with a range of -kr0.10 to -kr0.10. The previous quarter’s EPS was -kr0.10. NICA beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.14% of the time in the same period. In the last calendar year NICA has Preformed in-line its overall industry.
Next quarter’s earnings estimate for NICA is -kr0.10 with a range of -kr0.10 to -kr0.10. The previous quarter’s EPS was -kr0.10. NICA beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.14% of the time in the same period. In the last calendar year NICA has Preformed in-line its overall industry.

NICA Sales Forecast

Next quarter’s sales forecast for NICA is kr10.70M with a range of kr10.70M to kr10.70M. The previous quarter’s sales results were kr2.33M. NICA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.09% of the time in the same period. In the last calendar year NICA has Preformed in-line its overall industry.
Next quarter’s sales forecast for NICA is kr10.70M with a range of kr10.70M to kr10.70M. The previous quarter’s sales results were kr2.33M. NICA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.09% of the time in the same period. In the last calendar year NICA has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on SE:NICA
TipRanks AITipRanks
Not Ranked
TipRanks
kr2
Sell
49.25%
Upside
Downgraded
08/01/25
Nanologica AB's overall stock score is driven primarily by poor financial performance and unattractive valuation metrics, given its negative profitability and lack of dividend. While technical analysis indicates short-term positive momentum, overbought conditions suggest caution. The company's financial instability and reliance on external financing present significant risks.
AI Firm
kr1
Hold
-25.37%
Downside
Reiterated
06/20/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on SE:NICA
TipRanks AITipRanks
Not Ranked
TipRanks
kr2
Sell
49.25%
Upside
Downgraded
08/01/25
Nanologica AB's overall stock score is driven primarily by poor financial performance and unattractive valuation metrics, given its negative profitability and lack of dividend. While technical analysis indicates short-term positive momentum, overbought conditions suggest caution. The company's financial instability and reliance on external financing present significant risks.
AI Firm
kr1
Hold
-25.37%
Downside
Reiterated
06/20/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NICA Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Strong Buy
0
0
Buy
0
0
Hold
3
9
Sell
0
0
Strong Sell
0
0
total
3
9
In the current month, NICA has received 0 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. NICA average Analyst price target in the past 3 months is 1.01.
Each month's total comprises the sum of three months' worth of ratings.

NICA Stock Forecast FAQ

What is SE:NICA’s average 12-month price target, according to analysts?
Based on analyst ratings, Nanologica AB’s 12-month average price target is 1.01.
    What is SE:NICA’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for SE:NICA, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Nanologica AB a Buy, Sell or Hold?
        Nanologica AB has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Nanologica AB’s share price target?
          The average share price target for Nanologica AB is 1.01. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is kr1.01 ,and the lowest forecast is kr1.01. The average share price target represents -24.93% Decrease from the current price of kr1.34.
            What do analysts say about Nanologica AB?
            Nanologica AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Nanologica AB?
              To buy shares of SE:NICA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis